Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) Current ratio

Alert me on Current ratio

Pfizer Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.3×, up 0.1× from fiscal 2025 (1.2×). Over the past ten years it has ranged from 0.9× (fiscal 2019) to 1.6× (fiscal 2018); the current reading is higher than 27% of that period. That is in line with the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.2× (0.97%)
FY2024 1.2× 29.18%
FY2023 0.9× (25.47%)
FY2022 1.2× (13.04%)
FY2021 1.4× 3.40%
FY2020 1.4× 53.86%
FY2019 0.9× (43.89%)
FY2018 1.6× 15.90%
FY2017 1.4× 8.01%
FY2016 1.3× (15.99%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.3× 1.62%
Mar 2026 1.2× 7.48%
Dec 2025 1.2× (9.54%)
Sep 2025 1.3× 10.69%
42 more quarters

Against its own ten years

Low 0.9× High 1.6×
Ten-year median 1.3×
Current reading's percentile 27

Current ratio against peers

Company Current ratio
BMY Bristol Myers Squibb Company compare 1.5×
AMGN Amgen Inc. compare 1.4×
PFE Pfizer Inc. 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
SNY Sanofi compare 1.0×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
NVS Novartis AG compare 0.9×
GSK GSK PLC Sponsored ADR compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on PFE